Nontoxic Goiter.
Alkabban FM, Patel BC.
2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Nontoxic goiter-diffuse or nodular.
Maloof F, Wang CA, Vickery AL Jr.
Med Clin North Am. 1975 Sep;59(5):1221-32. doi: 10.1016/s0025-7125(16)31970-8.
Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.
Knobel M.
J Endocrinol Invest. 2016 Apr;39(4):357-73. doi: 10.1007/s40618-015-0391-7. Epub 2015 Sep 21.
A Review of the Pathology, Diagnosis and Management of Colloid Goitre.
Hoang VT, Trinh CT.
Eur Endocrinol. 2020 Oct;16(2):131-135. doi: 10.17925/EE.2020.16.2.131. Epub 2020 Oct 6.
Radioiodine for non-toxic diffuse goitre.
Hegedüs L, Bennedbaek FN.
Lancet. 1997 Aug 9;350(9075):409-10. doi: 10.1016/S0140-6736(05)64132-3.
The Influence of Diffuse Nontoxic Goiter on the State of Protective Mechanisms of the Oral Cavity in Children.
Godovantes OI, Kitsak TS, Vitkovsky OO, Kuzniak LV, Godovantes OS, Chaikovska NM, Fedoniuk LY.
J Med Life. 2020 Jan-Mar;13(1):21-25. doi: 10.25122/jml-2020-0013.
Assessment of nodular goitre.
Tonacchera M, Pinchera A, Vitti P.
Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):51-61. doi: 10.1016/j.beem.2009.08.008.
Prediction factors for the risk of diffuse non-toxic goiter development in type 2 diabetic patients.
Musiienko V, Sverstiuk A, Lepyavko A, Mazur L, Danchak S, Lisnianska N.
Pol Merkur Lekarski. 2022 Apr 19;50(296):94-98.
Diffuse nontoxic and multinodular goiter.
Nakhjavani M, Gharib H.
Curr Ther Endocrinol Metab. 1997;6:109-12.
Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?
Knobel M.
Front Endocrinol (Lausanne). 2016 May 23;7:48. doi: 10.3389/fendo.2016.00048. eCollection 2016.
